Skip to main content
KANGSTEM BIOTECH CO., LTD. logo

KANGSTEM BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 217730 ISIN · KR7217730001 KO Manufacturing
Open in API
Filings indexed 413 across all filing types
Latest filing 2026-04-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 217730

About KANGSTEM BIOTECH CO., LTD.

https://kangstem.com

KANGSTEM BIOTECH CO., LTD. is a biopharmaceutical company that researches and develops advanced stem cell therapies. The company focuses on creating treatments for rare, incurable, and autoimmune diseases, with a pipeline that includes therapeutic candidates for neurological disorders. Leveraging proprietary technologies for the isolation and mass culture of mesenchymal stem cells, Kangstem Biotech also develops and commercializes stem cell culture media and related cosmetic products. The company is dedicated to addressing unmet medical needs through the development of next-generation biopharmaceuticals.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a “주식등의 대량보유상황보고서” filed under Korea’s Capital Markets Act, detailing a beneficial owner’s shareholding above the 5% threshold and subsequent changes (including stock option grants). This matches the definition of a Major Shareholding Notification (crossing significant ownership levels).
2026-04-03 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal notification to the Korean Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사 신규선임). It details the date of election at the AGM, the new director’s biographical information, and changes in board composition. This clearly falls under announcements of changes in the company’s board of directors (Board/Management Information).
2026-03-31 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing reporting the grant of stock options (주식매수선택권 부여) by the company to its directors and employees. It is not a management change notice, earnings release, or proxy statement—it concerns a capital event (granting rights to issue new shares upon exercise). This corresponds to our category for share issuance and capital changes. Therefore, it should be classified under Share Issue/Capital Change (SHA).
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” (Annual General Meeting Results) and provides detailed voting results for each AGM agenda item, including approval of financial statements, election of directors, and other resolutions, as well as voting percentages. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the KRX (Korea Exchange). It provides the auditor's opinion (적정 - Unqualified), financial highlights (assets, liabilities, equity, profit/loss), and details regarding the audit process. While it contains financial data, it is a regulatory filing announcing the completion and submission of the audit report to the exchange, rather than the full annual report (10-K) itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2025
2026-03-20 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Independent Auditor's Report' (독립된 감사인의 감사보고서) for Kangstem Biotech, covering the fiscal year 2025. It includes the auditor's opinion, key audit matters, and the full set of consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows) along with detailed notes. Since this is a full audit report containing financial statements and is not an annual report (10-K) or a simple announcement, it falls under the 'Audit Report / Information' category. FY 2025
2026-03-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.